Introduction: The goal of treatment in brucellosis is to control symptoms to prevent the development of complications and relapse of infection. The aim of this study was to evaluate the risk factors for relapse in brucel...
Acinetobacter baumannii (A. baumannii) is a Gram-negative opportunistic and nosocomial pathogen that is associated with most of the hospital epidemics. Its success can be directly attributed to its ability to survive und...
Ceftolozane/tazobactam is a novel generation cephalosporin and β-lactamase inhibitor combination antibiotic. It was approved for the treatment of adults (18 years and older) with complicated intraabdominal infections use...
A Case Report: Mycobacterium fortuitum Spondylodiscitis
No Abstract
Osteoarticular Involvement and Inadequate Treatment of Brucellosis are Related to Relapse
Introduction: The goal of treatment in brucellosis is to control symptoms to prevent the development of complications and relapse of infection. The aim of this study was to evaluate the risk factors for relapse in brucel...
A Rare Presentation in Tularemia: Inguinally Located Glandular Tularemia
No Abstract
Acinetobacter baumannii Biofilm: Intervening Factors, Persistence, Drug Resistance, and Strategies of Treatment
Acinetobacter baumannii (A. baumannii) is a Gram-negative opportunistic and nosocomial pathogen that is associated with most of the hospital epidemics. Its success can be directly attributed to its ability to survive und...
Novel β-lactam/β-lactamase Inhibitor: Ceftolozane/tazobactam
Ceftolozane/tazobactam is a novel generation cephalosporin and β-lactamase inhibitor combination antibiotic. It was approved for the treatment of adults (18 years and older) with complicated intraabdominal infections use...